Phase I study of PKC412, a protein kinase C inhibitor, in combination with gemcitabine and cisplatin: Preliminary report of an ongoing phase I study
2000
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI